vs
Evolv Technologies Holdings, Inc.（EVLV）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Evolv Technologies Holdings, Inc.的1.8倍（$69.8M vs $38.5M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 28.3%，领先355.8%），Evolv Technologies Holdings, Inc.同比增速更快（32.3% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 31.8%）
该企业总部位于美国旧金山，是一家人工智能科技公司，成立于2007年，成立后累计获得超1.43亿美元投资，2016年时曾是全球融资规模最高的人工智能企业，业务聚焦电子商务、线上内容与交易领域。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
EVLV vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.8倍
$38.5M
营收增速更快
EVLV
高出11.1%
21.2%
净利率更高
RIGL
高出355.8%
28.3%
两年增速更快
RIGL
近两年复合增速
31.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $38.5M | $69.8M |
| 净利润 | $10.9M | $268.1M |
| 毛利率 | 48.4% | 91.5% |
| 营业利润率 | -20.7% | 33.2% |
| 净利率 | 28.3% | 384.0% |
| 营收同比 | 32.3% | 21.2% |
| 净利润同比 | 169.2% | 1769.2% |
| 每股收益（稀释后） | $0.07 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVLVRIGL
| Q4 25 | $38.5M | $69.8M | ||
| Q3 25 | $42.9M | $69.5M | ||
| Q2 25 | $32.5M | $101.7M | ||
| Q1 25 | $32.0M | $53.3M | ||
| Q4 24 | $29.1M | $57.6M | ||
| Q3 24 | $27.4M | $55.3M | ||
| Q2 24 | $25.2M | $36.8M | ||
| Q1 24 | $22.2M | $29.5M |
净利润EVLVRIGL
| Q4 25 | $10.9M | $268.1M | ||
| Q3 25 | $-1.8M | $27.9M | ||
| Q2 25 | $-40.5M | $59.6M | ||
| Q1 25 | $-1.7M | $11.4M | ||
| Q4 24 | $-15.7M | $14.3M | ||
| Q3 24 | $-30.4M | $12.4M | ||
| Q2 24 | $3.4M | $-1.0M | ||
| Q1 24 | $-11.3M | $-8.2M |
毛利率EVLVRIGL
| Q4 25 | 48.4% | 91.5% | ||
| Q3 25 | 49.7% | 93.2% | ||
| Q2 25 | 49.8% | 95.6% | ||
| Q1 25 | 59.8% | 91.7% | ||
| Q4 24 | 57.5% | 89.9% | ||
| Q3 24 | 57.8% | 85.5% | ||
| Q2 24 | 58.5% | 92.4% | ||
| Q1 24 | 54.8% | 93.1% |
营业利润率EVLVRIGL
| Q4 25 | -20.7% | 33.2% | ||
| Q3 25 | -20.1% | 40.9% | ||
| Q2 25 | -53.8% | 60.1% | ||
| Q1 25 | -45.0% | 23.9% | ||
| Q4 24 | -64.9% | 28.9% | ||
| Q3 24 | -70.0% | 25.4% | ||
| Q2 24 | -88.7% | 1.2% | ||
| Q1 24 | -98.8% | -23.6% |
净利率EVLVRIGL
| Q4 25 | 28.3% | 384.0% | ||
| Q3 25 | -4.2% | 40.2% | ||
| Q2 25 | -124.6% | 58.6% | ||
| Q1 25 | -5.3% | 21.5% | ||
| Q4 24 | -54.0% | 24.9% | ||
| Q3 24 | -111.3% | 22.5% | ||
| Q2 24 | 13.6% | -2.8% | ||
| Q1 24 | -50.8% | -27.9% |
每股收益（稀释后）EVLVRIGL
| Q4 25 | $0.07 | $14.11 | ||
| Q3 25 | $-0.01 | $1.46 | ||
| Q2 25 | $-0.25 | $3.28 | ||
| Q1 25 | $-0.01 | $0.63 | ||
| Q4 24 | $-0.10 | $0.82 | ||
| Q3 24 | $-0.19 | $0.70 | ||
| Q2 24 | $0.02 | $-0.06 | ||
| Q1 24 | $-0.07 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $49.1M | $155.0M |
| 总债务越低越好 | $28.6M | $52.5M |
| 股东权益账面价值 | $119.4M | $391.5M |
| 总资产 | $304.4M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.24× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资EVLVRIGL
| Q4 25 | $49.1M | $155.0M | ||
| Q3 25 | $56.2M | $137.1M | ||
| Q2 25 | $36.9M | $108.4M | ||
| Q1 25 | $35.0M | $77.1M | ||
| Q4 24 | $51.9M | $77.3M | ||
| Q3 24 | $56.0M | $61.1M | ||
| Q2 24 | $56.5M | $49.1M | ||
| Q1 24 | $81.0M | $49.5M |
总债务EVLVRIGL
| Q4 25 | $28.6M | $52.5M | ||
| Q3 25 | $28.5M | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $0 | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益EVLVRIGL
| Q4 25 | $119.4M | $391.5M | ||
| Q3 25 | $102.2M | $117.6M | ||
| Q2 25 | $92.7M | $81.9M | ||
| Q1 25 | $121.1M | $18.6M | ||
| Q4 24 | $117.7M | $3.3M | ||
| Q3 24 | $129.0M | $-14.6M | ||
| Q2 24 | $151.2M | $-29.9M | ||
| Q1 24 | $139.8M | $-31.7M |
总资产EVLVRIGL
| Q4 25 | $304.4M | $513.6M | ||
| Q3 25 | $304.3M | $242.5M | ||
| Q2 25 | $280.4M | $206.7M | ||
| Q1 25 | $256.0M | $176.0M | ||
| Q4 24 | $268.1M | $164.0M | ||
| Q3 24 | $278.5M | $139.4M | ||
| Q2 24 | $269.1M | $128.4M | ||
| Q1 24 | $280.0M | $126.5M |
负债/权益比EVLVRIGL
| Q4 25 | 0.24× | 0.13× | ||
| Q3 25 | 0.28× | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 0.00× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.43× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EVLVRIGL
| Q4 25 | $15.6M | $22.0M | ||
| Q3 25 | $3.5M | $24.0M | ||
| Q2 25 | $2.1M | $30.5M | ||
| Q1 25 | $-2.5M | $-893.0K | ||
| Q4 24 | $3.2M | $14.5M | ||
| Q3 24 | $3.7M | $21.7M | ||
| Q2 24 | $-21.6M | $302.0K | ||
| Q1 24 | $-16.2M | $-5.0M |
现金转化率EVLVRIGL
| Q4 25 | 1.43× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | -6.31× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
